Literature DB >> 29506391

Increased kynurenine plasma concentrations and kynurenine-tryptophan ratio in mild-to-moderate chronic obstructive pulmonary disease patients.

Angelo Zinellu1, Alessandro Giuseppe Fois2,3, Elisabetta Zinellu2,3, Elisabetta Sotgiu1, Salvatore Sotgia1, Dionigia Arru1, Arduino A Mangoni4, Ciriaco Carru1,5, Pietro Pirina2,3.   

Abstract

AIM: Since an increase in kynurenine (Kyn) plasma concentrations has been proposed as marker of immune system activation, we studied the associations between the Kyn levels and presence and severity of chronic obstructive pulmonary disease (COPD). METHODS &
RESULTS: Plasma Kyn, tryptophan (Trp) and Kyn/Trp ratio were measured in 43 COPD patients with clinically defined mild (n = 29) or moderate (n = 14) disease and 43 age- and sex-matched healthy controls. When compared with controls, COPD patients had significantly higher plasma Kyn concentrations and Kyn/Trp ratios. In multiple logistic regression analysis, after adjusting for clinical and demographic confounders, the Kyn/Trp ratio was independently associated with COPD severity. DISCUSSION &
CONCLUSION: Kyn and Kyn/Trp ratio might represent a new, sensitive, biomarker of systemic inflammation in COPD patients.

Entities:  

Keywords:  chronic obstructive pulmonary disease; inflammation; kynurenine; oxidative stress; tryptophan

Mesh:

Substances:

Year:  2018        PMID: 29506391     DOI: 10.2217/bmm-2017-0280

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  5 in total

Review 1.  Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Vanessa X Tan; Gilles J Guillemin
Journal:  Front Neurosci       Date:  2019-09-20       Impact factor: 4.677

2.  Effect of targeted nutrient supplementation on physical activity and health-related quality of life in COPD: study protocol for the randomised controlled NUTRECOVER trial.

Authors:  Rosanne Jhcg Beijers; Lieke E J van Iersel; Lisanne T Schuurman; Robert J J Hageman; Sami O Simons; Ardy van Helvoort; Harry R Gosker; Annemie Mwj Schols
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

3.  Reprogramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Haroon Arshad; Anastasios Siokis; Raimo Franke; Aamna Habib; Juan Carlos López Alfonso; Yuliya Poliakova; Eva Lücke; Katina Michaelis; Mark Brönstrup; Michael Meyer-Hermann; Ursula Bilitewski; Jordi Vila; Laurent Abel; Thomas Illig; Jens Schreiber; Frank Pessler
Journal:  Cells       Date:  2022-07-24       Impact factor: 7.666

4.  Metabolomics Reveals Dysregulated Sphingolipid and Amino Acid Metabolism Associated with Chronic Obstructive Pulmonary Disease.

Authors:  Jeeyoung Kim; Bharathi Suresh; Myoung Nam Lim; Seok-Ho Hong; Kye-Seong Kim; Ha Eun Song; Hyo Yeong Lee; Hyun Ju Yoo; Woo Jin Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-21

5.  Improved Voltammetric Determination of Kynurenine at the Nafion Covered Glassy Carbon Electrode - Application in Samples Delivered from Human Cancer Cells.

Authors:  Ilona Sadok; Katarzyna Tyszczuk-Rotko; Robert Mroczka; Jędrzej Kozak; Magdalena Staniszewska
Journal:  Int J Tryptophan Res       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.